MDMA Grows Its Ranks, Digs In On FDA Reform Process
This article was originally published in The Gray Sheet
Executive Summary
On the backdrop of health care reform and other changes in Washington, D.C., the Medical Device Manufacturers Association is seeing "significant growth," the group's president and CEO Mark Leahey said in an interview
You may also be interested in...
CDRH Slows Pace In 2011 Strategic Agenda, Focusing On Ongoing Efforts
In 2011, FDA's device center will focus largely on continuing or completing initiatives begun last year, including 510(k) reform, device reclassifications and interactive review improvements, according to the agency.
CDRH Slows Pace In 2011 Strategic Agenda, Focusing On Ongoing Efforts
In 2011, FDA's device center will focus largely on continuing or completing initiatives begun last year, including 510(k) reform, device reclassifications and interactive review improvements, according to the agency.
Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA
Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group